Anterogen.Co.,Ltd. logo

Anterogen.Co.,Ltd.

065660.KQ

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
5
Cost of Revenue
3
Gross Profit
2
Gross Margin
37.9%
Operating Income
-3
Operating Margin
-54.1%
Net Income
-2
Net Margin
-33.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-1
EBITDA Margin
-23.3%

2023

12/31/2023

Revenue
5
Cost of Revenue
3
Gross Profit
2
Gross Margin
41.0%
Operating Income
-4
Operating Margin
-78.1%
Net Income
-2
Net Margin
-43.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-0
EBITDA Margin
-7.5%

2022

12/31/2022

Revenue
5
Cost of Revenue
3
Gross Profit
2
Gross Margin
39.7%
Operating Income
-3
Operating Margin
-70.5%
Net Income
-5
Net Margin
-103.7%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-3
EBITDA Margin
-66.6%

2021

12/31/2021

Revenue
6
Cost of Revenue
3
Gross Profit
3
Gross Margin
47.7%
Operating Income
-2
Operating Margin
-32.3%
Net Income
-0
Net Margin
-6.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1
EBITDA Margin
20.0%

2020

12/31/2020

Revenue
3
Cost of Revenue
2
Gross Profit
1
Gross Margin
42.0%
Operating Income
-3
Operating Margin
-89.5%
Net Income
-3
Net Margin
-105.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-3
EBITDA Margin
-84.4%